The serum concentration of @entity1465 and @entity787 in 277 @entity356 was extensively studied. 8.6% for @entity1465 and 18% for @entity787 were regarded as positive. 9.4% of @entity1 showed elevated serum level for both @entity1465 and @entity787 , on the other hand 7% of the @entity1 showed high @entity1465 only. All of @entity1465 positive @entity1 had severe lymph nodal involvement. All cases of @entity1465 positive and 85% of @entity787 positive cases were classified as stage 4. Macroscopically, 85% of @entity1465 positive cases and 40% of @entity787 positive cases showed generalized type. Histological type was poorly differentiated @entity420 in 72% of @entity5 with elevated serum @entity1465 level, but in only 35% of @entity5 with elevated serum @entity787 level. The content of @entity1465 subunits in serum and @entity5 showed different levels among @entity1 . The @entity1465 positive cases did not reveal endocrine symptom. The prognosis of these @entity1 with elevated serum @entity1465 and @entity787 level were poor. One year survival rates were 0% and 30%, respectively. These results showed that both @entity1465 and @entity787 , especially when used in combination, was potentially useful marker for determination of staging, recurrence and prognosis in @entity356 .

[The significance of the measurement of a serum gonadotropin-like substance in XXXX ].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1465 :: ('93659', 'Gene') :: ['hCG'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'tumors'] @entity787 :: ('1084', 'Gene') :: ['CEA'] @entity420 :: ('MESH:D000230', 'Disease') :: ['adenocarcinoma'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric cancer', 'gastric cancers']
@entity356 :: (MESH:D013274,Disease) :: ['gastric cancer']
